Fresenius Targets Actavis With IP Suit Over Diprivan
Fresenius Kabi USA LLC launched a suit in Delaware federal court Thursday alleging Actavis Inc. and its subsidiary Watson Laboratories infringed four patents by attempting to market a generic form of...To view the full article, register now.
Already a subscriber? Click here to view full article